Skip to content
Ranked #116Desk pick
Hers

Mainstream telehealth GLP-1 access.

semaglutide
From $199/molowest dose rung
tirzepatide
$299/mobrand-name

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.

Before enrolling

Limited public information on program details

vs
Ranked #165
LIV by WellNow

Patients in IL, IN, MI, NY, or PA who want all-inclusive compounded semaglutide from a company with physical clinics behind it, and who have budgeted for the higher-dose rung.

semaglutide
From $195/molowest dose rung
tirzepatide
Not confirmed for LIV by WellNow.
Before enrolling

The price follows the DOSE: $195/month covers the average 1 mg dose, but 1.7 mg or 2.4 mg costs $265/month, and the headline says "no hidden fees"

Our review of Hers gives it 76/100 (C), while our review of LIV by WellNow gives it 71/100 (C). The score breakdown shows where each provider does better.

Desk Score, dimension by dimension

Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.

Hers

76/100

C

Overall

LIV by WellNow

71/100

C

Price transparency

78
94

State access

86
42

Molecule range

79
66

Onboarding speed

74
71

Support responsiveness

71
71

Licensing & trust

55
77

The spec sheet

Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.

FieldHersLIV by WellNow
SemaglutideFrom $199/molowest dose rung
Full plan terms

$199/mo (starting dose, compounded)

From $195/molowest dose rung
Full plan terms

$195/mo month-to-month (compounded, at the average 1 mg dose); $175/mo paid quarterly · higher doses of 1.7 mg or 2.4 mg are $265/mo, or $249/mo paid quarterly

Tirzepatide$299/mobrand-name
Full plan terms

$299/mo (starting dose, plus a separate fee, brand-name)

Not confirmed for LIV by WellNow.
CoverageAll 50 states5 states (IL, IN, MI, NY, PA)
Brand-nameBrand-name option listedBrand-name option listed
Oral optionNot confirmed hereNot confirmed here
Best forMainstream telehealth GLP-1 access.Patients in IL, IN, MI, NY, or PA who want all-inclusive compounded semaglutide from a company with physical clinics behind it, and who have budgeted for the higher-dose rung.
Desk Score76/100C71/100C

The verdict

Desk pick — Hers

Hers has the higher Desk Score, but LIV by WellNow may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.

Choose Hers if…

Mainstream telehealth GLP-1 access.

From $199/mo (lowest dose rung) sema · $299/mo (brand-name) tirz · All 50 states

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.

Choose LIV by WellNow if…

Patients in IL, IN, MI, NY, or PA who want all-inclusive compounded semaglutide from a company with physical clinics behind it, and who have budgeted for the higher-dose rung.

From $195/mo (lowest dose rung) sema · 5 states (IL, IN, MI, NY, PA)

Assume any provider we list may compensate us. We may earn a referral commission at no extra cost to you, and compensation does not change the Desk Score.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.